SCHEMBL3468657

SCHEMBL3468657

Cc1ccc(-c2ccco2)cc1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.55
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HDAC2 Q92769 1/20 0.44
PRMT6 Q96LA8 1/20 0.42
ERN1 O75460 1/20 0.42
ADORA2A P29274 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CASP1 P29466 1/20 0.42
PGR P06401 1/20 0.41
KEAP1 Q14145 1/20 0.41
CHEK1 O14757 1/20 0.41
FLT3 P36888 1/20 0.40
SRD5A1 P18405 1/20 0.40
LPL P06858 1/20 0.40
LIPG Q9Y5X9 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24196355 0.85 ALDH1A1 (0.57) TAAR1ALDH1A1KDM4ESMN1; SMN2HDAC2
SCHEMBL15519549 0.82 TAAR1 (0.61) TAAR1ALDH1A1KDM4EHDAC2PRMT6
SCHEMBL3717306 0.82 TDP2 (0.51) TAAR1ALDH1A1KDM4EPRMT6ERN1
SCHEMBL24714531 0.79 TAAR1 (0.52) TAAR1HDAC2PRMT6ERN1ADORA2A
SCHEMBL3717305 0.78 TAAR1 (0.46) TAAR1ALDH1A1KDM4EPRMT6ERN1
SCHEMBL3792516 0.78 TRIM24 (0.41) TAAR1ALDH1A1KDM4ESMN1; SMN2HDAC2
SCHEMBL19475516 0.77 ADORA2A (0.56) TAAR1ALDH1A1KDM4ESMN1; SMN2ERN1
SCHEMBL30820503 0.77 ADORA2A (0.56) TAAR1ALDH1A1KDM4ESMN1; SMN2ERN1
SCHEMBL31201086 0.76 FLT3 (0.48) TAAR1KDM4EPRMT6ERN1ADORA2A
SCHEMBL3467297 0.75 PRMT6 (0.47) TAAR1KDM4EHDAC2PRMT6ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
WO-2010085968-A1 TOLUIDINE SULFONAMIDES AND THEIR USE AS HIF-INHIBITORS EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) (DE) 2010-08-05 WO disclosed
WO-2010076034-A1 TOLUIDINE SULFONAMIDES AND THEIR USE AS-INHIBITORS EUROPEAN MOLECULAR BIOLOGY LABORATORY (EMBL) (DE) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 TAAR1 3812/4885ALDH1A1 813/4885KDM4E 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.